U.S. Gynecological Chairs And Tables Market Size, Share & Trends Analysis Report By Product (Gynecological Chairs, Gynecological Tables), By Application (Urology Surgery, Pelvic Surgery), By End-use, And Segment Forecasts, 2025 - 2030

Market Size & Trends

The U.S. gynecological chairs and tables market size was valued at USD 194.8 million in 2024 and is projected to grow at a CAGR of 6.5% from 2025 to 2030. Growth is propelled by increasing focus on women’s health, innovations in medical furniture, and a rise in outpatient procedures. The market benefits from the higher incidence of gynecological issues, growing awareness of preventive care, and a shift toward minimally invasive treatments. According to the American Cancer Society, about 13,820 invasive cervical cancer cases were reported in 2024. Expanding ambulatory surgical centers and modern clinics further boost product adoption nationwide.

The U.S. gynecological chairs and tables industry is poised for steady growth in the coming years, driven by the increasing prevalence of gynecological diseases such as cervical cancer, uterine fibroids, and endometrial cancer. These conditions demand consistent diagnosis, monitoring, and treatment, which in turn elevates the need for advanced gynecological examination and surgical equipment, including chairs and tables. As healthcare providers focus more on women's health, the demand for ergonomic, adjustable, and technologically integrated equipment continues to grow.

In addition to cervical cancer, uterine fibroids-noncancerous growths in the uterus-affect millions of women in the U.S., especially those in their 30s and 40s. According to the National Institutes of Health (NIH), up to 70-80% of women may develop fibroids by the age of 50. These patients often require regular ultrasounds, biopsies, or surgical interventions such as myomectomy or hysterectomy, all of which necessitate the use of appropriate gynecological equipment. Likewise, endometrial cancer, which affects the lining of the uterus, is also on the rise. In 2024, the American Cancer Society estimated over 66,000 new cases of uterine cancer in the U.S., making it the most common cancer of the female reproductive organs.

Furthermore, the rising healthcare expenditure is expected to propel market growth over the forecast period. As per the data published by the U.S. Centers for Medicare & Medicaid Services, in December 2023, healthcare spending in the U.S. increased by 4.1% and reached USD 4.5 trillion In 2022. In addition, the rising number of hospitals in the U.S. is expected to improve the demand for medical devices in the U.S., propelling the U.S. gynecological chairs & tables market growth. 

Source: Health Forum LLC, an affiliate of the American Hospital Association, Grand View Research Analysis

The growing number of efforts by key stakeholders to enhance awareness regarding U.S. gynecological disorders is expected to drive treatments, leading to an increased demand for U.S. gynecological tables and chairs. Various entities, including industry participants, governmental organizations, and medical experts, actively engage in initiatives to raise awareness about U.S. gynecological conditions. For instance, in January 2024, Hologic, Inc., a leading provider of women's health solutions, launched the "Better is Possible" campaign in New York, Los Angeles, to raise awareness and education about uterine health. Abnormal uterine bleeding (AUB), including heavy and disruptive periods, impacts over 10 million women in the U.S. annually, leading to symptoms such as fatigue, pain, and prolonged menstrual cycles. A primary contributor to AUB is uterine fibroids, affecting approximately 77% of women during their reproductive years. Despite the high prevalence of these conditions, many women remain unaware of the treatment options available. Hologic's Vice President of Marketing for Gynecological Surgical Solutions emphasized the importance of this initiative.

"Roughly two-thirds of women say that their period has impacted their day-to-day life, but until now, there's been a glaring absence of discussion around solutions. Through this campaign, we want to show women who experience painful periods, uncontrolled bleeding or other uterine health issues, that they don't have to suffer in silence. When it comes to periods, it can be so difficult to differentiate between what is normal and what isn't. We're proud to equip women with the resources they need to start the conversation and feel empowered when talking to their doctor about their periods and play an active role in their treatment plan."

Market Concentration & Characteristics

U.S. gynecological chairs and tables market exhibits moderate industry concentration, with several key players dominating the market. Initiatives to raise awareness about U.S. gynecological conditions and treatment options further stimulate market growth. Overall, the market is dynamic, driven by innovations to improve the efficiency and effectiveness of gynecological examinations and surgeries while prioritizing patient well-being.

U.S. gynecological chairs and tables industry is undergoing significant transformation driven by rising innovation. Manufacturers are focusing on advanced features such as improved ergonomics, motorized adjustments, antimicrobial materials, and integrated diagnostic tools to enhance patient comfort and clinical efficiency. The emphasis is on developing smart, user-friendly equipment tailored to outpatient and minimally invasive procedures. Recently, companies like Oakworks Medical and Midmark have introduced new models aligning with these goals. Furthermore, with the Biden administration’s increased funding for women's health initiatives in 2025, including expanded access to reproductive care, demand for technologically advanced gynecological equipment is expected to rise significantly.

Regulations play a critical role in shaping the U.S. gynecological chairs and tables industry. The FDA’s stringent approval process ensures products meet safety and efficacy standards, impacting design, materials, and functionality. Compliance with regulations such as the Medical Device Reporting (MDR) and quality system requirements also increases production costs and time-to-market. Additionally, healthcare facility regulations under OSHA and ADA influence ergonomic and accessibility features. Recent updates promoting patient safety and infection control, along with growing scrutiny on women’s health equipment, have encouraged manufacturers to prioritize innovation and compliance. These regulations ultimately enhance patient outcomes but require ongoing industry adaptability and investment.

Mergers and acquisitions (M&A) in the U.S. gynecological industry are on the rise, driven by the need for technological advancement, expanded service offerings, and market consolidation. Companies aim to enhance their product portfolios, especially in women’s health diagnostics and surgical equipment. In January 2025, CooperCompanies completed the acquisition of a specialty surgical equipment firm, strengthening its gynecological product line. Such M&A activity reflects growing investor interest in the sector and a strategic focus on improving access to advanced gynecological care.

Product substitutes in the U.S. gynecological industry are emerging due to advancements in non-invasive diagnostic tools and telehealth services. Portable ultrasound devices, wearable health monitors, and home-based testing kits are increasingly used as alternatives to traditional in-clinic procedures involving gynecological chairs and tables. These substitutes offer convenience and reduce patient visits, particularly in rural and underserved areas. In recent news, FemTech startups in the U.S. introduced AI-enabled pelvic health apps and remote diagnostic tools in early 2025, gaining traction among younger patients. While not complete replacements, these alternatives are reshaping how preventive and routine gynecological care is delivered.

The U.S. gynecological chairs and tables market is experiencing notable global growth, driven by increased focus on women’s health, rising demand for advanced medical equipment, and enhanced healthcare infrastructure across regions. U.S. manufacturers are entering emerging markets through strategic partnerships, expanded distribution, and global medical trade events. For instance, in August 2022, Michigan-based Haworth launched the Zody II and Zody LX chairs, optimized for use with height-adjustable tables and continuing the legacy of its 17-year-old Zody line. As international healthcare systems increasingly invest in women’s health, demand for ergonomic and innovative gynecological equipment is rising, boosting U.S. companies’ global reach.

Product Insights

The U.S. gynecological chairs segment accounted for the largest market share of 44.5% in 2024. These chairs are designed to provide comfort, accessibility, and support during Gynecological examinations, surgeries, and treatments. Key features include adjustable heights, stirrups for patient positioning, and ergonomic designs to accommodate various procedures. Technological advancements, the increasing prevalence of gynecological disorders, and rising healthcare spending contribute to market growth. Moreover, efforts to enhance patient experience and improve clinical outcomes drive innovation in gynecological chairs and tables, ensuring their continued significance in women's healthcare.

The U.S. gynecological tables segment is expected to grow at a CAGR of 6.51% over the forecast period. U.S. gynecological tables are specialized medical equipment for conducting gynecological examinations, procedures, and surgeries. The rising prevalence of gynecological diseases, such as cervical cancer, ovarian, uterine, vaginal, and vulvar cancer, is expected to drive the demand for U.S. Gynecological tables. In addition, increased awareness regarding the importance of preventive screenings and early detection of gynecological conditions encourages healthcare facilities to invest in equipment like U.S. gynecological tables to bolster these services.

Application Insights

The pelvic surgery segment accounted for a significant market share of 33.4% in 2024. This growth is driven by the rising prevalence of pelvic organ prolapse, endometriosis, and uterine fibroids. Technological advancements in surgical procedures and increased demand for outpatient treatments are fueling the adoption of specialized gynecological chairs and tables. According to the CDC, over 600,000 hysterectomies are performed annually in the U.S., indicating strong procedural volume. Moreover, growing investments in ambulatory surgical centers and ergonomic innovations by key manufacturers are supporting the segment’s expansion and enhancing patient comfort during pelvic surgeries.

The urology surgery segment is expected to register the fastest CAGR of 8.1% in the U.S. gynecological chairs and tables market over the forecast period. This growth is attributed to rising cases of urinary incontinence, pelvic floor disorders, and bladder issues among women. According to the Urology Care Foundation, one in three women experiences a pelvic floor disorder, increasing demand for urology-related procedures. The growing adoption of minimally invasive surgeries and advanced diagnostic tools is fueling the need for ergonomic, adjustable chairs and tables. Investments in ambulatory surgical centers and women’s health clinics further support this segment’s rapid expansion in the U.S.

End-use Insights

The office-based surgery (OBS) segment accounted for a significant revenue share of 35.9%, in 2024. This growth is driven by the increasing preference for minimally invasive procedures, cost-effectiveness, and improved patient convenience. OBS settings are gaining popularity for low-to-moderate complexity surgeries, supported by advancements in surgical instruments and anesthesia protocols. Additionally, favorable reimbursement models and shorter recovery times contribute to the segment’s expansion. The trend reflects a broader shift from traditional hospital-based care to more accessible, decentralized surgical options, especially in dermatology, ophthalmology, and minor general surgeries. This growth is expected to continue through 2030.

The Department of Veterans Affairs (VA) segment shows the highest CAGR of 7.5% over the forecast period. This growth is fueled by the VA’s increasing focus on improving women veterans' healthcare services, including gynecological care. Expanding infrastructure, modernization of VA medical facilities, and rising demand for specialized women’s health services within the VA system are driving the adoption of advanced, ergonomic gynecological chairs and tables.

Country Insights

California Gynecological Chairs And Tables Market Trends

California leads the U.S. gynecological chairs and tables market, with a share of 15.3% in 2024. It is attributed to its extensive healthcare infrastructure and high demand for advanced medical equipment. The state's large population and emphasis on women's health services contribute to its dominant position. Major healthcare facilities in California are investing in state-of-the-art gynecological chairs and tables to enhance patient care and streamline procedures. Additionally, the presence of key market players and ongoing technological innovations further bolster California's market share.

Florida Gynecological Chairs And Tables Market Trends

Florida is rapidly emerging as the fastest-growing segment in the U.S. gynecological chairs and tables market. This growth is fueled by the state's expanding healthcare sector and increasing focus on women's health initiatives. Florida's aging population and rising awareness of preventive gynecological care have led to a surge in demand for modern examination equipment. Healthcare providers in the state are upgrading their facilities with advanced gynecological chairs and tables to meet this demand. Furthermore, supportive government policies and investments in healthcare infrastructure are accelerating market growth in Florida.

Key U.S. Gynecological Chairs And Tables Market Company Insights

The U.S. Gynecological chairs and tables market is highly competitive, with key players such as STERIS, Baxter (Hill Rom Holdings), and The Brewer Company, LLC holding significant positions. For instance, President and Chief Executive Officer of STERIS, said,

“The continued momentum in our Healthcare segment reflects solid procedure volume growth in the United States and the easing of supply chain constraints, which allowed us to continue to reduce backlog levels. In addition, revenue within our Life Sciences segment improved during the quarter. Our revenue outlook for fiscal 2024 has increased as we continue to experience outperformance within the Healthcare segment, offsetting macro challenges impacting demand in our other segments.”

The major companies are undertaking various organic and inorganic strategies such as new product development, collaborations, acquisitions, mergers, and regional expansion for serving the unmet needs of their customers.

Recent Developments

• In February 2023, The Brewer Company, a U.S.-based clinical furniture manufacturing company, launched its versatile Versa Fixed-Height Examination Table in the North American markets.

U.S. Gynecological Chairs And Tables Market Report Scope

U.S. Gynecological Chairs And Tables Market Report Segmentation

This report forecasts regional-level revenue growth and analyzes the latest industry trends and opportunities in each sub-segment from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the U.S. gynecological chairs and tables market report on the basis of product, application, end-use and region:

• Product Outlook (Volume, Units; Revenue, USD Million, 2018 - 2030)

  • U.S. Gynecological Chairs

    • Electric

    • Manual

  • U.S. Gynecological Tables

    • Powered

    • Non-powered

  • Operating Table Boot Stirrups

• Application Outlook (Volume, Units; Revenue, USD Million, 2018 - 2030)

  • Urology surgery

  • Pelvic surgery

  • Others

• End-use Outlook (Volume, Units; Revenue, USD Million, 2018 - 2030)

  • Department of Veterans Affairs (VA)

  • Office-Based Surgery (OBS)

  • Others

• State Outlook (Volume, Units; Revenue, USD Million, 2018 - 2030)

  • California

  • Texas

  • Florida

  • New York

  • Pennsylvania

  • Illinois

  • Ohio

  • Georgia

  • North Carolina

  • Michigan

  • Rest of the U.S. States